NHS to launch subscription service to encourage R&D
11 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The NHS is set to launch a new payment method for antibiotic development to incentivise pharmaceutical companies.
List view / Grid view
Antibiotics
Combination therapy ‘favourable’ in long-term acne treatment
29 April 2019 | By European Pharmaceutical Review
According to Rutgers researchers, physicians are scaling back on prescribing antibiotics for long-term acne treatment in favour of a combination of therapies.
Big pharma accused of no action on antibiotic threat
29 March 2019 | By European Pharmaceutical Review
The pharmaceutical industry needs to match words with action on researching new antibiotics to address the threat posed by drug-resistant superbugs...
Expansion of the global antibiotics market size
26 February 2019 | By European Pharmaceutical Review
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases...
Whitepaper: Analytical criteria in bacterial endotoxin testing using LAL and rFC
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
Biomanufacturing sector set to ‘boost its efficiency’
28 September 2018 | By Mike Stones
The next five years will see game-changing improvements made in upstream, downstream and continuous bioprocessing, predicts one industry specialist...
Whitepaper: BIOshell™ IgG 1000 Å C4 UHPLC column for improved biomacromolecule separations
28 June 2018 | By Merck
Monoclonal antibodies (mAbs) are widely manufactured by many biopharmaceutical companies to treat a myriad of diseases ranging from Alzheimer’s disease, Parkinson’s disease, ulcerative colitis, and many types of cancers...
New compound as effective as FDA-approved drugs against life-threatening infections
20 June 2018 | By European Pharmaceutical Review
Researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the FDA to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.
Oral antibiotics may raise risk of kidney stones
14 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Paediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones...
Antibiotic use increases risk of severe viral disease in mice
28 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Killing gut bacteria with drugs weakens immune response...
Scientists develop rapid test that determines antibiotic resistance
16 March 2018 | By European Pharmaceutical Review
Scientists in Germany have developed a test using electric fields and Raman spectroscopy to ascertain specific antibiotic resistance of pathogens and thus enable the prescription of effective treatment.
Antibiotics may impact cancer treatment efficacy
6 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Improper use of antibiotics may have an unintended consequence of hampering cancer treatments...
DNA microarrays and multidrug resistant bacteria
1 March 2018 | By Dr Payam Behzadi
In parallel with the use of a wide range of antibiotics for treating infectious diseases worldwide, antimicrobial resistance has significantly increased. For this reason, the application of an advanced pangenomic technique like DNA microarray can be an effective, rapid, accurate, sensitive, specific and flexible methodology for detecting, identifying and determining…
Old antibiotic compounds could become tomorrow’s life-saving drugs
7 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Scientists and chemists are re-examining old compounds to see whether they could hold the key to a future drug to combat increasingly resistant bacteria...
Computational method provides a potential boon in fighting antibiotic resistance
22 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A team of computer scientists have developed an algorithm that can rapidly search massive databases to discover novel variants of known antibiotics...